Researchers have discovered that a protein called cardiotrophin 1 (CT1) can trick the heart into growing in a healthy way and pumping more blood, just as it does in response to exercise and pregnancy. They show that this good kind of heart growth is very different from the harmful enlargement of the heart that occurs during heart failure. They also show that CT1 can repair heart damage and improve blood flow in animal models of heart failure.
The results are published in Cell Research. The research team is from The Ottawa Hospital, the University of Ottawa, the University of Ottawa Heart Institute and Carleton University.
Heart failure is a leading cause of death and disability in high-income countries and a growing problem around the world. It occurs when the heart can’t pump enough blood through the body, often because a heart attack has damaged the heart muscle tissue.
“When part of the heart dies, the remaining muscles try to adapt by getting bigger, but this happens in a dysfunctional way and it doesn’t actually help the heart pump more blood,” said Dr. Lynn Megeney, senior author of the study and a senior scientist at The Ottawa Hospital and professor at the University of Ottawa. “We found that CT1 causes heart muscles to grow in a more healthy way and it also stimulates blood vessel growth in the heart. This actually increases the heart’s ability to pump blood, just like what you would see with exercise and pregnancy.”
Dr. Megeney and his colleagues conducted a variety of studies in mice, rats and cells growing in the lab. In addition to CT-1, some of the studies involved a drug called phenylephrine (PE), which is known to cause the bad kind of heart growth. They found:
• Heart muscle cells treated with CT-1 become longer, healthier fibres, while those treated with PE just grow wider.
• CT-1 causes blood vessels to grow alongside the new heart muscle tissue and increases the heart’s ability to pump blood, while PE does neither.
• When CT-1 treatment stops, the heart goes back to its original condition, just like it does when exercise or pregnancy end. However, the dysfunctional heart growth caused by PE is irreversible.
• CT-1 dramatically improves heart function in two animal models of heart failure – one caused by a heart attack (affecting the left side of the heart) and one caused by high blood pressure in the lungs (pulmonary hypertension, affecting the right side of the heart).
• Both CT-1 and PE stimulate heart muscle growth through a molecular pathway that has traditionally been associated with promoting cell suicide (apoptosis), but CT-1 has a better ability to control this pathway.
“This experimental therapy is very exciting, particularly because it shows promise in treating both left and right heart failure,” said Dr. Duncan Stewart, a cardiologist, senior scientist and co-senior author on the paper who is also Executive Vice-President of Research at The Ottawa Hospital and a professor at the University of Ottawa. “Currently, the only treatment for right heart failure is a transplant. And although we have drugs that can reduce the symptoms of left heart failure, we can’t fix the problem, and left heart failure often leads to right heart failure over time.”
“An intriguing aspect of this research was how human CT1 was able to promote a healthy growth response in multiple animal models,” said co-author Dr. Patrick Burgon, scientist at the University of Ottawa Heart Institute and assistant professor at the University of Ottawa. “This suggests the action of CT1 is universally conserved and puts us much closer to therapy.”
The researchers also note that while exercise could theoretically have the same benefits as CT-1, people with heart failure are usually limited in their ability to exercise.
Dr. Megeney and Dr. Stewart have patents pending for the use of CT-1 to treat heart conditions and they hope to develop partnerships to test this protein in patients. If this testing is successful it will take a number of years for the treatment to become widely available.
The Latest on: Heart failure
[google_news title=”” keyword=”heart failure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Bringing awareness to heart health with Go Red for Womenon April 26, 2024 at 10:53 am
Heart disease is the leading cause of death for women. Cardiovascular disease claims more lives of women than all cancers combined. Go Red for Women is an organization meant ...
- 4-year-old who received new heart after waiting 1,025 days goes home from hospitalon April 26, 2024 at 10:43 am
According to her parents and doctor, 4-year-old Arctura was born with a congenital heart defect, which the Centers for Disease Control and Prevention notes is the most common type of birth defect.
- YOUR HEALTH: Solution to overlooking dangerous heart conditionon April 26, 2024 at 10:18 am
DCM enlarges the heart, preventing it from pumping enough blood, and a recent study indicated dozens of inherited genes are the cause.
- First generic pimobendan chewable tablets for canine congestive heart failure receives FDA approvalon April 26, 2024 at 6:44 am
The drug from Cronus Pharma contains the same active ingredient as Boehringer Ingelheim's Vetmedin.
- Irregular bone marrow cells may increase heart disease riskon April 26, 2024 at 4:00 am
Over time, bone marrow stem cells develop key genetic errors and pass them on to immune cells. This may increase the risk of developing heart disease.
- Diabetes drug shows promise for the treatment of acute heart failureon April 25, 2024 at 2:04 pm
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a ...
- Study: Women with heart disease prescribed cholesterol-lowering drugs less often than menon April 25, 2024 at 3:36 am
Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, contravening recommended treatment guidelines, according to new research released Thursday.
- Scientific Breakthrough Could Tackle Depression and Heart Diseaseon April 24, 2024 at 9:00 pm
A team of scientists at Tampere University in Finland identified a "gene module" consisting of 256 functionally related, co-expressed genes that contribute to the development of both diseases. The ...
- Heart failure mortalities increase — and moreon April 24, 2024 at 2:45 pm
Medical Watch Digest for April 24 A troubling trend when it comes to heart health. Patients and their doctors are failing when it comes to heart care. Heart failure rates are now on pace to wipe out ...
- Unveiling immune features of heart failure paves the way for targeted therapieson April 24, 2024 at 1:25 pm
In a recent study published in the Science Bulletin, researchers comprehensively examined the composition and phenotypic features of myeloid cells in human failing hearts at a single-cell level, ...
via Google News and Bing News